BioReady Streptavidin Gold Nanospheres - 40 nm
nanoComposixBioReady Gold Nanospheres - Streptavidin - 40 nm, 10 OD in aqueous conjugation buffer
BioReady Gold Nanospheres - Streptavidin - 40 nm, 10 OD in aqueous conjugation buffer
BioReady Gold Nanoshells - Streptavidin - 150 nm, 10 OD in aqueous conjugation buffer
Dried blood spot specimen stability makes it a practical alternative to venous blood. Instead of traveling to a clinic to get blood drawn, a blood spot sample can be taken at a convenient site and mailed to a laboratory. It opens new possibilities in testing, such as comparison of historical to current patient results; simplified blood sampling for patients in remote locations, for those who are homebound or those that pre…
Dried blood spot specimen stability makes it a practical alternative to venous blood. Instead of traveling to a clinic to get blood drawn, a blood spot sample can be taken at a convenient site and mailed to a laboratory. It opens new possibilities in testing, such as comparison of historical to current patient results; simplified blood sampling for patients in remote locations, for those who are homebound or those that prefer…
Glicentin is a 69 amino acid N-terminal peptide derived from proglucagon (PG 1-69) by posttranslational processing in the intestine by intestinal L-cells. Glicentin can further be processed into oxyntomodulin, corresponding to proglucagon residues no 33-69. These peptides are released simultaneously upon stimulation. Glicentin is a pro-glucagon derived gut peptide that is released in the gut in response to feed intake. It is…
Nova Max ® Plus™ incorporates advanced technology for accurate and precise self-monitoring of blood glucose and ketones by people with diabetes. Nova Max Plus has the most comprehensive features for fast, easy, and error-free blood glucose and ketone monitoring.
quick, accurate oximetry assessment in cardiac catheterization
Designed with input from top molecular diagnostic assay manufacturers, the RapiDxFire Lyo-Flex 1-Step RT-qPCR 5x Master Mix supports the development of diagnostic devices and assays that meet healthcare provider and consumer demand for fast, accurate results. With consistent results in a liquid state at room temp or in a lyophilised state, this master mix will help you achieve predictable performance in unpredictable conditio…
The STAT-Site® WB analyzer from EKF Diagnostics is used to quantitatively determine β-ketones (Beta-Hydroxybutyrate or β-HB) and glucose in whole blood taken from capillary or venous samples.
IsoFast® Bst Polymerase is a recombinant form of the large fragment of Bst DNA polymerase, containing 5′-3′ polymerase activity and strand displacement activity.
IsoFast® Bst 1-Step Mix is a dual enzyme system for rapid and sensitive isothermal amplification of RNA targets in one step.
Having rapid multiplex PCR testing at the Point of Need can make life better for millions of people in hospitals, clinics, pharmacies, care homes, and a wide variety of clinical settings. Portable and simple to use, the Q-POC™ platform is a rapid multiplex PCR testing system that delivers fast, accurate, and actionable results in approximately 30 minutes at the Point of Need, to those who need it most.

From collecting samples to reading results, the Q-POC™ SARS-CoV-2 assay has been developed considering patient and user experience at every step of the COVID-19 testing process. The test delivers rapid PCR results in approximately 30 minutes at the Point of Need, on the accurate and portable Q-POC™ platform.
Diagnosing, treating and managing clinically similar respiratory infections can be challenging. The Q-POC™ SARS-CoV-2, Flu A/B & RSV multiplex assay provides rapid detection and differentiation of three leading respiratory diseases in just ~35 minutes. Running on the “one sample, one test” portable Q-POC™ platform, the test provides results you can trust at the Point of Need.

PanbioTM COVID-19 Ag Rapid Test Device for professional use is currently the only rapid antigen test with: CE Mark and World Health Organisation (WHO) Emergency Use Listing (EUL) for use on people with or without symptoms Performance data specifically for use on children who are 15 years and younger, including infants
This new generation analyzer Microsemi CRP LC-767G is more compact and proposes enhanced software and network connectivity providing higher memory, usability plus a new ratio: Granulocytes-to-Lymphocytes Ratio (GLR).
Accu-Chek Active test strips are designed for easy handling and allow for dosing outside of the meter
Next-generation point of care diagnostic platform - Next-generation microfluidic technology on the LumiraDx Platform enables lab-comparable performance across a broad menu of diagnostic assays.
The LumiraDx CRP Test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify CRP levels in whole blood and plasma. Used with the LumiraDx Platform, the Test delivers rapid, quantitative results in 4 minutes at the point of care.
The LumiraDx D-Dimer Test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify D-Dimer levels in whole blood and plasma. It is the only direct fingerstick D-Dimer assay available today*, aiding healthcare professionals to exclude deep vein thrombosis (DVT) and pulmonary embolism (PE) in symptomatic patients with confidence** - in only 6 minutes.
The LumiraDx HbA1c test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify HbA1c in fingerstick and venous whole blood. Used with the LumiraDx Platform, the LumiraDx HbA1c test delivers rapid, reliable results in approximately < 7 minutes at the point of care.
The LumiraDx INR Test measures prothrombin time reported as International Normalized Ratio (INR) from a single, direct fingerstick blood sample – all in less than 90 seconds*. The Test is used for monitoring patients on oral anticoagulation therapy with Vitamin-K Antagonist (VKA) drugs. Used with the LumiraDx Instrument, the Test delivers rapid results at the point of care.
The LumiraDx NT-proBNP test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify NT-proBNP in human capillary and venous whole blood and plasma samples (Lithium Heparin). Used with the LumiraDx Platform, the LumiraDx NT-proBNP test delivers rapid, reliable results in 12 minutes at the point of care.